주식회사 아넥슨
US ˙ NasdaqGS ˙ US03589W1027

소개

이 페이지에서는 Jung Choi의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

내부자 포지션이 보고된 기업

SEC 서류에 따르면 Jung Choi 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권 소유권 최근 보고된 보유 주식
US:ANNX / Annexon, Inc. Director 33,000
US:GBT / Global Blood Therapeutics Inc. See Remarks 0
차트 해석 방법

아래 차트는 Jung Choi에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자 매입 ANNX / Annexon, Inc.: 단기 이익 분석

이 섹션에서는 ANNX / Annexon, Inc.에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일 티커 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최고까지
일수
최고
가격
최고
이익 ($)
최고 수익률 (%)
2025-12-01 ANNX Choi Jung 33,000 4.1900 33,000 4.1900 138,270 52 6.9600 91,410 66.11

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

ANNX / Annexon, Inc. Insider Trades
내부자 매매 ANNX / Annexon, Inc.: 단기 손실 분석

이 섹션에서는 ANNX / Annexon, Inc.에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일 티커 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최저까지
일수
최저에서
가격
회피된
최대 손실($)
회피된
최대 손실율(%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

ANNX / Annexon, Inc. Insider Trades
내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Jung Choi의 내부자의 전체 거래 목록입니다.

보고일 거래일 보고 티커 증권 코드 10b5-1 지분 잔여 지분 변동률
(%)
지분
가치
거래
가치
잔여
가치
2025-12-03 2025-12-01 4 ANNX Annexon, Inc.
Common Stock
P - Purchase 33,000 33,000 4.19 138,270 138,270
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -25,000 0 -100.00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -226,672 0 -100.00
2022-09-29 2022-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift -73,855 226,672 -24.58
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,674 300,527 0.90 3.40 9,092 1,021,792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,674 300,527 0.90 3.40 9,092 1,021,792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 74,964 295,179 34.04 3.40 254,878 1,003,609
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,275 220,215 1.04 65.82 149,740 14,494,551
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 16,902 217,940 8.41 16.40 277,193 3,574,216
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,861 201,038 -0.92 68.15 -126,827 13,700,740
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,208 202,899 1.10
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,763 200,691 1.40
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,126 197,928 -1.06 32.40 -68,882 6,412,867
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,145 200,054 3.17
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 28,628 28,628
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17,668 17,668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17,668 17,668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,763 16,577 -14.29
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -956 191,374 -0.50 29.87 -28,556 5,716,341
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,763 192,330 1.46
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 12,080 -20.00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 6,250 -33.33
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 0 -100.00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,340 189,567 -1.73 29.33 -97,962 5,560,000
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 192,907 4.91
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 15,100 -16.67
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 9,375 -25.00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 2,875 -50.00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,743 182,367 -2.01 27.33 -102,296 4,984,090
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 186,110 5.09
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,762 19,340 -12.50
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,370 183,887 -0.74 29.85 -40,894 5,489,027
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,762 185,257 1.51
2021-09-03 2021-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 128 182,495 0.07 24.39 3,122 4,451,053
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 15,100 -16.67
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 9,375 -25.00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 2,875 -50.00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,743 182,367 -2.01 27.33 -102,296 4,984,090
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 186,110 5.09
2021-06-04 2021-06-02 4 ANNX Annexon, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 22,102 22,102
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38,739 38,739
2021-03-03 2021-02-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 140 177,090 0.08 36.21 5,069 6,412,429
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 18,120 -14.29
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 12,500 -20.00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 5,750 -33.33
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 0 -100.00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4,646 176,950 -2.56 49.49 -229,931 8,757,256
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13,083 181,596 7.76
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 21,140 -12.50
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 15,625 -16.67
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 8,625 -25.00
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 4,063 -49.99
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -6,239 168,513 -3.57 67.48 -421,008 11,371,257
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13,082 174,752 8.09
2020-08-04 2020-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 162 161,670 0.10 36.68 5,942 5,930,056
2020-06-03 2020-06-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 42,400 42,400
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38,500 38,500
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 24,160 24,160
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 18,750 -14.29
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 11,500 -20.00
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 8,125 -33.34
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,570 161,508 -2.16 65.26 -232,978 10,540,012
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10,063 165,078 6.49
2020-02-04 2020-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 286 155,015 0.18 36.68 10,490 5,685,950
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5,000 0 -100.00
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,479 154,729 -1.58 76.88 -190,586 11,895,566
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5,000 157,208 3.28
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 21,875 -12.50
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 14,375 -16.67
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 12,188 -25.00
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,990 152,208 -2.55 54.25 -216,458 8,257,284
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10,062 156,198 6.89
2019-08-05 2019-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 285 146,136 0.20 36.68 10,454 5,360,268
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 5,000 -28.57
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 145,851 -0.47 58.51 -40,489 8,533,742
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 146,543 1.38
2019-04-10 2019-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 269 144,543 0.19 36.68 9,867 5,301,837
2019-02-14 2018-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 277 144,274 0.19 35.53 9,842 5,126,055
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 17,250 -14.29
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 16,250 -20.00
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 25,000 25,000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,515 143,997 -1.72 48.44 -121,827 6,975,215
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,938 146,512 4.97
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 20,125 -12.50
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 20,313 -16.66
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,440 139,574 -2.41 43.15 -148,436 6,022,618
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,937 143,014 5.10
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2,675 -18.35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2,675 -18.35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 74,964 -0.26
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,077 -1.02 48.25 -67,550 6,565,715
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,477 0.44 3.40 2,043 467,422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,477 0.44 3.40 2,043 467,422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136,275 0.15 3.40 673 463,335
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 136,077 -1.16 48.25 -77,200 6,565,715
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,276 -15.50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,276 -15.50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,162 -0.26
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 137,677 -1.01 45.50 -63,700 6,264,304
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,077 0.43 3.40 2,043 472,862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,077 0.43 3.40 2,043 472,862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137,875 0.14 3.40 673 468,775
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 137,677 -1.15 45.50 -72,800 6,264,304
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,877 -13.42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,877 -13.42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,360 -0.26
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 139,277 -1.00 54.15 -75,810 7,541,850
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140,677 0.43 3.40 2,043 478,302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140,677 0.43 3.40 2,043 478,302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 139,475 0.14 3.40 673 474,215
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 139,277 -1.14 54.15 -86,640 7,541,850
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4,478 -11.83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4,478 -11.83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,558 -0.26
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 140,877 -0.98 62.95 -88,130 8,868,207
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142,277 0.42 3.40 2,043 483,742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142,277 0.42 3.40 2,043 483,742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141,075 0.14 3.40 673 479,655
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 140,877 -1.12 62.95 -100,720 8,868,207
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 7,000 -22.22
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 142,477 -0.48 62.30 -43,112 8,876,317
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 143,169 1.42
2018-02-14 2017-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 676 135,931 0.50 13.69 9,254 1,860,895
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 23,000 23,000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 35,000 35,000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 24,375 -14.29
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,405 140,058 -0.99 59.60 -83,738 8,347,457
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,063 141,463 2.96
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 9,000 -18.18
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 137,400 -0.50 57.90 -40,067 7,955,460
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 138,092 1.47
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 11,000 -15.38
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -686 136,092 -0.50 58.15 -39,891 7,913,750
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 136,778 1.48
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5,079 -10.58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5,079 -10.58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -198 75,756 -0.26
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 134,778 -1.17 52.85 -84,560 7,123,017
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,378 -1.02 52.85 -73,990 7,207,577
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,778 0.44 3.40 2,043 468,445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,778 0.44 3.40 2,043 468,445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136,576 0.15 3.40 673 464,358
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 13,000 -13.33
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -877 136,378 -0.64 52.10 -45,692 7,105,294
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 137,255 1.48
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5,680 -9.57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5,680 -9.57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 75,954 -0.26
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 135,255 -1.02 36.55 -51,170 4,943,570
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136,655 0.44 3.40 2,043 464,627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136,655 0.44 3.40 2,043 464,627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 135,453 0.15 3.40 673 460,540
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 135,255 -1.17 36.55 -58,480 4,943,570
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,281 -8.73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,281 -8.73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,152 -0.26
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,855 -1.01 39.75 -55,650 5,439,986
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138,255 0.44 3.40 2,043 470,067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138,255 0.44 3.40 2,043 470,067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137,053 0.14 3.40 673 465,980
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 136,855 -1.16 39.75 -63,600 5,439,986
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,882 -8.03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,882 -8.03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,350 -0.26
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 138,455 -1.00 32.65 -45,710 4,520,556
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,855 0.43 3.40 2,043 475,507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,855 0.43 3.40 2,043 475,507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 138,653 0.14 3.40 673 471,420
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 138,455 -1.14 32.65 -52,240 4,520,556
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7,483 -7.43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7,483 -7.43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,548 -0.26
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 140,055 -0.99 30.00 -42,000 4,201,650
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141,455 0.43 3.40 2,043 480,947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141,455 0.43 3.40 2,043 480,947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 140,253 0.14 3.40 673 476,860
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 140,055 -1.13 30.00 -48,000 4,201,650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,084 -6.92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,084 -6.92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,746 -0.26
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 141,655 -0.98 30.00 -42,000 4,249,650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143,055 0.42 3.40 2,043 486,387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143,055 0.42 3.40 2,043 486,387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141,853 0.14 3.40 673 482,300
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 141,655 -1.12 30.00 -48,000 4,249,650
2017-08-14 2017-08-11 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 15,000 15,000
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 28,438 -12.50
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,527 145,790 -1.04 25.10 -38,328 3,659,329
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,062 147,317 2.84
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,685 -6.47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,685 -6.47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,944 -0.26
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 143,255 -0.97 30.00 -42,000 4,297,650
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144,655 0.42 3.40 2,043 491,827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144,655 0.42 3.40 2,043 491,827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 143,453 0.14 3.40 673 487,740
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 143,255 -1.10 30.00 -48,000 4,297,650
2017-02-14 2017-01-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 658 144,855 0.46 13.73 9,034 1,988,859
2017-02-14 2016-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 591 144,197 0.41 15.20 8,983 2,191,794
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 49,000 49,000
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 32,500 32,500
2016-10-03 2016-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9,286 9,286
2016-03-14 2016-03-10 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9,286 9,286
2016-03-14 2016-02-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 143,606 0.52 16.09 12,051 2,310,621
2016-03-14 2015-08-17 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25,000 25,000 20.00 500,000 500,000
2016-02-03 2016-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 168,606 0.45 16.09 12,051 2,712,871
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25,000 167,857 17.50 20.00 500,000 3,357,140
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285,714
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285,714
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)